Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $37.14 USD
Change Today -0.36 / -0.96%
Volume 794.2K
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Nancy A. Simonian M.D.

Director and Chairman of Nominating & Corporate Governance Committee, Seattle Genetics, Inc.
AgeTotal Calculated CompensationThis person is connected to 26 board members in 2 different organizations across 4 different industries.

See Board Relationships
53--

Background*

Dr. Nancy A. Simonian, M.D., has been the Chief Executive Officer at Syros Pharmaceuticals Inc. since April 2013. Dr. Simonian served as the Chief Medical Officer of Clinical, Medical & Regulatory Affairs at Millennium Pharmaceuticals, Inc. She served as the Chief Medical Officer of Millennium Pharmaceuticals Inc. since 2006. While at Millennium, Dr. Simonian has built a strong clinical development organization which effectively executes on a diverse pipeline of product ...

Read Full Background

Corporate Headquarters*

21823 30th Drive SE
Bothell, Washington 98021

United States

Phone: 425-527-4000
Fax: 425-527-4001

Board Members Memberships*

2006-2011
Former Director and Member of Science Committee
2012-Present
Director and Chairman of Nominating & Corporate Governance Committee
2013-Present
Chief Executive Officer and Director

Education*

BA
Princeton University
MD
University of Pennsylvania - School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGEN:US $37.14 USD -0.36

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEATTLE GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.